Where to be online

10+ can't-miss virtual business and innovation events in Houston for November​

Log on to one of these informative online events happening throughout the rest of the month. Getty Images

November is usually the last busy month for business events before the end of the year and ahead of the holidays, and this year — even though events have pivoted to virtual gatherings — is no different.

From panels and ask-me-anything meetings to summits and startup competitions, here are over 10 Houston innovation events you can attend virtually via online meetings. This month in particular there's the return of The Houston Innovation Summit and the brand new awards program called, The Listies (nominate now for those). Be sure to register in advance, as most will send an access link ahead of the events.

November 5 — Dell Technologies Ask Me Anything

Dell Technologies is hosting an "Ask Me Anything" session for the Ion community. During this time, attendees can ask experts anything in regards to IT pain points during these times. Entrepreneurs may also use this time to brainstorm the back end IT Infrastructure of their business.

The event will take place online on Thursday, November 5, at 10 am. Register here.

November 5-6 — Greentown Labs Climatetech Summit

Join Greentown Labs for its first Climatetech Summit for a deep dive into scaling climate action. Across the two days, attendees will engage with Greentown's pillars of climate action — technology, finance, policy, and justice — discover groundbreaking startups and their climatetech solutions, learn from industry experts, and forge meaningful connections with entrepreneurs, investors, business leaders, policymakers, startup support organizations, and other climate champions.

The event will take place online on Thursday, November 5, and Friday, November 6. Register here.

November 10 — Igniting Leadership: The State of COVID Vaccines

Join Ignite Healthcare Network for a special night of discussion hosted by IGNITE Steering Committee member Susan Feigin Harris about the status of COVID19 vaccine development with Dr. Maria Elena Bottazzi, Co-director of Texas Children's Center for Vaccine Development.

The event will take place online on Tuesday, November 10, at 6 pm. Register here.

November 10-12 — Texas Life Sciences Forum

The Texas Life Science Forum is the premier life science event in Texas that brings together members from industry, emerging life science companies, academic, and investors. The 2020 event will be virtual and will still be the "must attend" event for anyone in the life science industry in Texas or affiliated with innovation at the life science academic institutions. This event represents an opportunity to meet investors, learn about promising life science companies, to learn about opportunities for entrepreneurs, investment professionals, big pharma, academics and business executives serving the life science industry.

The event will take place online on Tuesday, November 10, to Thursday, November 12. Register here.

November 12 — Plaza Tec: Funding Fundamentals

Though Latinx-owned businesses and startups make up at least 38 percent of businesses in the Houston area, there is still a lack of access to capital blocking growth and progress for Latinx founders.

In this discussion presented by The Ion, representatives from baMa and NextSeed will join together to discuss angel investing and crowdfunding options for Latinx founders and what challenges one might face when seeking capital.

The event will take place online on Thursday, November 12, at 5:30 pm. Register here.

November 12 — Women in Tech and Biz

If you're interested in hearing from some badass women in tech and business, come to the virtual Women in Tech + Biz event created by the Liu Idea Lab for Innovation and Entrepreneurship. The event will be split into two sections — one focused on entrepreneurship and the other focusing more on software and engineering — followed by networking.

The event will take place online on Thursday, November 12, at 6 pm. Register here.

November 13 — Climathon 2020: Hacking Solutions to Houston’s Climate Challenges

On Earth Day this year, the City of Houston published its first Climate Action Plan. The plan is the culmination of thousands of volunteer time from industry professionals, policy stakeholders, and community advocates. Together the working groups have laid out a concise plan to address the climate challenges that Houston faces along with maintaining a leadership role in the energy transition. This year's Climathon will look to realize some of the goals of the plan through design sprints led by local subject matter experts in the areas of transportation, energy innovation, building optimization, and materials management.

The event will take place online on Friday, November 13, at 1 pm. Register here.

November 16-20 — The Houston Innovation Summit

The Houston Innovation Summit — THIS — celebrates Houston's innovation ecosystem during Global Entrepreneurship Week (GEW). THIS responds to 2020 with a special focus on the intersection of Impact and Innovation, spotlighting Houstonians at the forefront of education, ecosystems, inclusion, and policy. Join Impact Hub Houston and Houston's startup and small business community for a week of exciting programs and connect with the thinkers, doers, makers and innovators driving Houston forward.

The event will take place online on Monday, November 16, to Friday, November 20. Register here.

November 17 — Struggles and Bubbles: Pivoting during a Pandemic

Join General Assembly Houston to listen to a panel of startup founders who will share their journey and entrepreneurial struggles, and what it really takes to launch a startup during global pandemic, and scale a startup.

The event will take place online on Tuesday, November 17 at 5 pm. Register here.

November 17-19 — Capital Factory's Texas Startup Roadshow

For the first time, Capital Factory is taking its roadshow online. For three days, the organization will be introducing investors to the various innovative cities across the Lone Star State.

Houston will be the city of focus on Wednesday, November 18.

The event will take place online on Tuesday, November 17, to Thursday, November 19. Register here.

November 20 — The Listies

Let's toast to the entrepreneurial spirit of Houston in a time when celebrating victories is more important than ever. Introducing the Listies, brought to you Houston Exponential and InnovationMap, commemorating the launch of HTX TechList, Houston's innovation discovery platform.

The event will take place online on Friday, November 20, at 3 pm. Register here.

Trending News

Building Houston

 
 

Tvardi Therapeutics Inc. has fresh funds to support its drug's advancement in clinical trials. Photo via Getty Images

A Houston-based clinical-stage biopharmaceutical company has raised millions in its latest round.

Tvardi Therapeutics Inc. closed its $74 million series B funding round led by new investors New York-based Slate Path Capital, Florida-based Palkon Capital, Denver-based ArrowMark Partners, and New York-based 683 Capital, with continued support and participation by existing investors, including Houston-based Sporos Bioventures.

"We are thrilled to move out of stealth mode and partner with this lineup of long-term institutional investors," says Imran Alibhai, CEO at Tvardi. "With this financing we are positioned to advance the clinical development of our small molecule inhibitors of STAT3 into mid-stage trials as well as grow our team."

Through Slate Path Capital's investment, Jamie McNab, partner at the firm, will join Tvardi's board of directors.

"Tvardi is the leader in the field of STAT3 biology and has compelling proof of concept clinical data," McNab says in the release. "I look forward to partnering with the management team to advance Tvardi's mission to develop a new class of breakthrough medicines for cancer, chronic inflammation, and fibrosis."

Tvardi's latest fundraise will go toward supporting the company's products in their mid-stage trials for cancer and fibrosis. According to the release, Tvardi's lead product, TTI-101, is being studied in a Phase 1 trial of patients with advanced solid tumors who have failed all lines of therapy. So far, the drug has been well-received and shown multiple durable radiographic objective responses in the cancer patients treated.

Dr. Keith Flaherty, who is a member of Tvardi's scientific advisory board and professor of medicine at Harvard Medical School, offered his support of the company.

"STAT3 is a compelling and validated target. Beyond its clinical activity, Tvardi's lead molecule, TTI-101, has demonstrated direct downregulation of STAT3 in patients," he says in the release. "As a physician, I am eager to see the potential of Tvardi's molecules in diseases of high unmet medical need where STAT3 is a key driver."

Trending News